AstraZeneca
AZN
#43
Rank
HK$2.527 T
Marketcap
HK$1,631
Share price
2.19%
Change (1 day)
40.33%
Change (1 year)

Revenue for AstraZeneca (AZN)

Revenue in 2024: HK$419.79 Billion

According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is HK$454.69 Billion. In 2024 the company made a revenue of HK$419.79 Billion an increase over the revenue in the year 2023 that were of HK$357.78 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AstraZeneca from 1996 to 2024

Annual revenue

Year Revenue Change
2024HK$419.79 B17.33%
2023HK$357.78 B3.25%
2022HK$346.51 B18.77%
2021HK$291.76 B41.4%
2020HK$206.33 B8.65%
2019HK$189.90 B9.78%
2018HK$172.98 B-1.44%
2017HK$175.51 B-1.6%
2016HK$178.37 B-6.86%
2015HK$191.50 B-6.88%
2014HK$205.65 B3.15%
2013HK$199.37 B-8.05%
2012HK$216.82 B-16.89%
2011HK$260.89 B0.77%
2010HK$258.90 B1.79%
2009HK$254.35 B4.16%
2008HK$244.19 B5.96%
2007HK$230.47 B11.93%
2006HK$205.90 B10.89%
2005HK$185.69 B11.52%
2004HK$166.50 B13.97%
2003HK$146.10 B6.17%
2002HK$137.61 B-25.01%
2001HK$183.50 B29.87%
2000HK$141.29 B-1.35%
1999HK$143.22 B88.15%
1998HK$76.12 B9.69%
1997HK$69.40 B-21.48%
1996HK$88.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$720.83 B 58.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$443.33 B-2.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$491.14 B 8.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$342.96 B-24.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$464.81 B 2.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$371.76 B-18.24%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$78.74 B-82.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$502.47 B 10.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$375.74 B-17.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$331.30 B-27.14%๐Ÿ‡ฌ๐Ÿ‡ง UK